Abstract
McLeod syndrome is an X-linked multi-system disorder that is classified with the neuroacanthocytosis syndromes. It is caused by mutations of the XK gene encoding the XK protein, a membrane transport protein of yet unknown function. Hematologically, McLeod syndrome is characterized by an absent Kx erythrocyte antigen, weak expression of Kell antigens, acanthocytosis, and compensated hemolysis. Asymptomatic male McLeod carriers have elevated serum creatine kinase levels, and are prone to develop neurological symptoms at a mean onset ranging from 30 to 40 years. Neuromuscular manifestations include myopathy, sensory-motor axonal neuropathy, and cardiomyopathy. Central nervous system manifestations resemble Huntington’s disease, with a choreatic movement disorder, subcortical cognitive deficits, psychiatric abnormalities, and generalized seizures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen FH, Krabbe SMR, Corcoran PA (1961) A new phenotype (McLeod) in the Kell blood-group system. Vox Sang 6: 555–560.
Bunney WE, Bunney BG (2000) Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev 31: 138–146.
Critchley EM, Clark DB, Wikler A (1968) Acanthocytosis and neurological disorder without betalipoproteinemia. Arch Neurol 18: 134–140.
Danek A, Uttner I, Vogl T, Tatsch K, Witt TN (1994) Cerebral involvement in McLeod syndrome. Neurology 44: 117–120.
Danek A, Tison F, Rubio J, Oechsner M, Kalckreuth W, Monaco AP (2001) The chorea of McLeod syndrome. Mov Dis 16: 882–889.
Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HHM, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP (2001) McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50: 755–764.
Faillace RT, Kingston WJ, Nanda NC, Griggs RC (1982) Cardiomyopathy associated with the syndrome of amyotrophic chorea and acanthocytosis. Ann Intern Med 96: 616–617.
Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King RH, Jacobs JM (1991) Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114: 13–49.
Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington’s disease. Neurosci Lett 133: 257–261.
Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP (1994) Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77: 869–880.
Ho MF, Chalmers RM, Davis MB, Harding AE, Monaco AP (1996) A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 39: 672–675.
Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, Daniels G, Kollias S, Hess K (2001) McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 49: 384–392.
Jung HH, Russo D, Redman C, Brandner S (2001) Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve 24: 1346–1351.
Jung HH, Brandner S (2002) Malignant McLeod myopathy. Muscle Nerve 26: 424–427.
Kartsounis LD, Hardie RJ (1996) The pattern of cognitive impairments in neuroacanthocytosis. A frontosubcortical dementia. Arch Neurol 53: 77–80.
Kawakami T, Takiyama Y, Sakoe K, Ogawa T, Yoshioka T, Nishizawa M, Reid ME, Kobayashi O, Nonaka I, Nakano I (1999) A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci 166: 36–39.
Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, Redman C (1999) Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 94: 1440–1450.
Lee S, Russo D, Redman C (2000) Functional and structural aspects of the Kell blood group system. Transfus Med Rev 14: 93–103.
Levine IM, Estes JW, Looney JM (1968) Hereditary neurological disease with acanthocytosis. A new syndrome. Arch Neurol 19: 403–409.
Malandrini A, Fabrizi GM, Truschi F, Di Pietro G, Moschini F, Bartalucci P, Berti G, Salvadori C, Bucalossi A, Guazzi G (1994) Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family. J Neurol Sci 124: 89–94.
Marsh WL, Marsh NJ, Moore A, Symmans WA, Johnson CL, Redman CM (1981) Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang 40: 403–411.
Oechsner M, Buchert R, Beyer W, Danek A (2001) Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis. J Neurol Neurosurg Psychiatry 70: 517–520.
Ring HA, Serra-Mestres J (2002) Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 72: 12–21.
Rovito DA, Pirone FJ (1963) Acanthrocytosis associated with schizophrenia. Am J Psychiatry 120: 182–185.
Russo D, Redman C, Lee S (1998) Association of XK and Kell blood group proteins. J Biol Chem 273: 13950–13956.
Schwartz SA, Marsh WL, Symmans A, Johnson CL, Mueller KA (1982) New clinical features of McLeod syndrome. Transfusion 22: 404.
Stanfield GM, Horvitz HR (2000) The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol Cell 5: 423–433.
Swash M, Schwartz MS, Carter ND, Heath R, Leak M, Rogers KL (1983) Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy. Brain 106: 717–733.
Wimer BM, Marsh WL, Taswell HF, Galey WR (1977) Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 36: 219–224.
Witt TN, Danek A, Reiter M, Heim MU, Dirschinger J, Olsen EG (1992) McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations. J Neurol 239: 302–306.
Nicholl DJ, Sutton I, Dotti MT, Supple SG, Danek A, Lawden M (2002) Florid white matter abnormalities on MRI in neuroacanthocytosis. Mov Dis 17: S174–S175.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer
About this chapter
Cite this chapter
Jung, H.H. (2004). McLeod Syndrome: A Clinical Review. In: Danek, A. (eds) Neuroacanthocytosis Syndromes. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2898-9_6
Download citation
DOI: https://doi.org/10.1007/1-4020-2898-9_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2897-7
Online ISBN: 978-1-4020-2898-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)